Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures
Clinical trial NCT01227902 · COMPLETED
Trial details
- NCT number
- NCT01227902
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2012-12-01
- Enrollment
- 203
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.